文献速递牙体牙髓病牙周病口腔黏膜病

生物光子学在口腔疾病诊断与管理中的应用:叙述性综述

Biophotonics in the diagnosis and management of oral disease: A narrative review.
PubMed 文献 · J Am Dent Assoc · 2026-10-30

本叙述性综述评估了生物光子学方法在口腔疾病诊断和治疗中的应用,证据按层级优先纳入Cochrane系统评价、Meta分析、指南和共识。结果显示定量光诱导荧光对龋齿诊断准确性高,光动力疗法对口腔白斑有效,光生物调节有指南级推荐用于预防口腔黏膜炎;其他适应症证据有限,仍属研究性。

要点

  • 定量光诱导荧光诊断早期釉质龋的Se为0.86、Sp为0.82。
  • 光动力疗法治疗口腔白斑的合并应答率约76%。
  • 光生物调节预防口腔黏膜炎获指南级推荐。

核心结论

  • 证据仅支持3种生物光子学应用用于临床:光生物调节预防口腔黏膜炎、光动力疗法治疗口腔白斑、荧光基龋齿检测;其他适应症仍属研究性。

研究设计与样本

  • 叙述性综述,按证据层级优先纳入Cochrane系统评价、Meta分析、临床指南和共识声明,涵盖龋齿、牙周和种植体周病、口腔潜在恶性疾患(OPMD)、口腔癌和牙体牙髓病。

主要发现

  • 定量光诱导荧光检测咬合面龋齿诊断准确性高,2025年Meta分析报告早期釉质病变的Se为0.86、Sp为0.82、AUC为0.81至0.93。
  • Cochrane综述报告口腔癌和OPMD的Se高但Sp较低(Se 0.87,Sp 0.50)。
  • 光动力疗法在口腔白斑的合并应答率约76%,在OPMD中合并应答率为60.6%。
  • 最强的临床证据支持光生物调节,有指南级推荐用于预防口腔黏膜炎。
  • 牙周和种植体周病、龋齿治疗及牙体牙髓应用证据有限,无法推荐。

关键数值与推荐

  • 定量光诱导荧光诊断早期釉质龋:Se 0.86,Sp 0.82,AUC 0.81至0.93(2025年Meta分析)。
  • 口腔癌和OPMD诊断:Se 0.87,Sp 0.50(Cochrane综述)。
  • 光动力疗法治疗口腔白斑合并应答率约76%,OPMD合并应答率60.6%。
  • 光生物调节预防口腔黏膜炎获指南级推荐。

临床怎么用

  • 临床可应用光生物调节预防口腔黏膜炎、光动力疗法治疗口腔白斑及荧光基方法检测龋齿;其他适应症应视为研究性,需谨慎解读监管许可和营销声明。

局限性

  • 证据在不同学科间参差不齐,牙周和种植体周病、龋齿治疗及牙体牙髓应用证据有限,无法形成推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Conventional visual and radiographic examination reliably detects advanced lesions but lacks sensitivity (Se) for early ones, blinded by the complex oral environment. Biophotonic methods use light-tissue interactions to noninvasively reveal structural changes for improved clinical decision making. This review appraises biophotonic modalities spanning diagnostic and therapeutic applications in oral disease. TYPES OF STUDIES REVIEWED: This narrative review, informed by an evidence hierarchy, prioritized Cochrane systematic reviews, meta-analyses, clinical guidelines, and consensus statements across caries, periodontal and peri-implant disease, oral potentially malignant disorders (OPMD), oral cancer, and endodontics. Clinical, in vivo, and in vitro studies were included when higher-level evidence was absent. RESULTS: The evidence was mixed across disciplines. Quantitative light-induced fluorescence found high diagnostic accuracy in occlusal caries detection, with a 2025 meta-analysis reporting an Se of 0.86, specificity (Sp) of 0.82, and an area under the curve of 0.81 through 0.93 for incipient enamel lesions. A Cochrane review reported high Se but lower Sp for oral cancer and OPMD (Se 0.87, Sp 0.50). Photodynamic therapy achieved a pooled response rate of approximately 76% in oral leukoplakia and 60.6% across OPMD. The strongest clinical evidence supports photobiomodulation, with a guideline-level recommendation for the prevention of oral mucositis. Limited evidence precludes recommendations for periodontal and peri-implant disease, caries treatment, and endodontic applications. CONCLUSIONS AND PRACTICAL IMPLICATIONS: Despite mechanistic promise, evidence supports only 3 biophotonic applications for clinical use: photobiomodulation for the prevention of oral mucositis, photodynamic therapy for oral leukoplakia, and fluorescence-based caries detection; other indications remain investigational. Clinicians should carefully interpret regulatory clearance and marketing claims when clinical evidence is absent.

来源:J Am Dent Assoc,查看原文。版权归原作者所有。

引用

  1. Hiltch G, Steier L, de Figueiredo JAP, et al. Biophotonics in the diagnosis and management of oral disease: A narrative review. J Am Dent Assoc. 2026. PMID: 42961380. doi:10.1016/j.adaj.2026.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。